The development of autoantibodies in POTS could potentially be due to a dysregulation of an interleukin, such as is seen in the pathogenesis of SLE with elevations of IL-21, TNF, and INFγ, as observed in our patients [65]. Here, TNF is linked to systemic lupus erythematosus.